Glucagon‐like peptide‐1 (GLP‐1), a prototype of enteroglycemic physiologically released by enteroendocrine L‐cells, has been indicated to be essential for glucose homeostasis and is used to treat diabetes in response to food intake and metabolism modulation.18, 19. This evidence concerns the gene GLP1R and diabetes mellitus.